ALTERITY THERAPEUTICS LIMITED - AMERICAN DEPOSITAR
4.5100
04-2月-25 15:45:00
15 分の遅延
株式
-0.4800
-9.62%
本日の幅
4.5100 - 5.1000
ISIN
N/A
ソース
NASDAQ
-
Appendix 4C – Q3 FY24 Quarterly Cash Flow Report
30 4 2024 06:25:00 提供 Nasdaq GlobeNewswire
-
29 4 2024 06:25:00 提供 Nasdaq GlobeNewswire
-
17 4 2024 06:25:00 提供 Nasdaq GlobeNewswire
-
Alterity Therapeutics to Present New Data on ATH434 at the World Orphan Drug Congress USA 2024
10 4 2024 06:25:00 提供 Nasdaq GlobeNewswire
-
Alterity Therapeutics Receives a A$3.9 Million Research & Development Tax Incentive Refund
26 3 2024 09:25:00 提供 Nasdaq GlobeNewswire
-
20 2 2024 09:25:00 提供 Nasdaq GlobeNewswire
-
06 2 2024 06:25:00 提供 Nasdaq GlobeNewswire
-
Alterity Therapeutics to Participate in the ShareCafe Hidden Gems Webinar This Week
29 1 2024 06:24:00 提供 Nasdaq GlobeNewswire
-
22 1 2024 06:25:00 提供 Nasdaq GlobeNewswire
-
Alterity Therapeutics Appoints Phillip Hains as Chief Financial Officer
20 12 2023 23:30:00 提供 Nasdaq GlobeNewswire
-
04 12 2023 15:35:00 提供 Nasdaq GlobeNewswire
-
04 12 2023 06:25:00 提供 Nasdaq GlobeNewswire
-
27 11 2023 06:25:00 提供 Nasdaq GlobeNewswire
-
Alterity Therapeutics Announces Presentation of New Data Demonstrating Novel Mechanisms of ATH434
16 11 2023 06:25:00 提供 Nasdaq GlobeNewswire
-
08 11 2023 06:25:00 提供 Nasdaq GlobeNewswire
-
Appendix 4C – Q1 FY24 Quarterly Cash Flow Report
30 10 2023 06:25:00 提供 Nasdaq GlobeNewswire
-
Alterity Therapeutics Presents New Data on Multiple System Atrophy, a Rare Parkinsonian Disorder
31 8 2023 06:25:00 提供 Nasdaq GlobeNewswire
-
23 8 2023 06:25:00 提供 Nasdaq GlobeNewswire
-
22 8 2023 06:25:00 提供 Nasdaq GlobeNewswire
-
Alterity Therapeutics Receives a $4.74 million Research & Development Tax Incentive Refund
15 8 2023 06:25:00 提供 Nasdaq GlobeNewswire